AI Science Tracker

University of Chicago Pritzker School of Molecular Engineering

2 discoveries from 2023 to 2026

Discoveries

ElectrolyteGPT can generate new formulations for battery development

University of Chicago researchers trained a GPT model with a new notation (fLine) to generate complete battery electrolyte formulations, including solvent ratios, salt concentrations and temperature. Several AI-proposed compositions were synthesized and, per the release, performed on par with the state of the art in lithium metal batteries. No cycling or capacity figures are given, the work is early, and generated candidates still need experimental verification.

Technology: ElectrolyteGPT (GPT with fLine notation)

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Generated solvents and formulations were synthesized and fabricated, found to meet the target property requirements, and enabled long-term cycling in anode-free lithium metal batteries.
  • Still unknown: The release states the limited data and parameter set, and that the results matched but did not exceed top existing electrolytes; the abstract states no limitations.
  • AI role: A transformer-based generative model (ElectrolyteGPT) generated candidate solvents and electrolyte formulations conditioned on property targets.

Evidence sources: https://news.uchicago.edu/story/electrolytegpt-can-generate-new-formulations-battery-development · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1021/jacsau.5c01628&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Machine-learning-guided screening discovers potent innate immune signaling modulators

At the University of Chicago, an active-learning pipeline iteratively selected molecules from a 139,998-compound library for in-vitro assays of NF-κB and interferon regulatory factor (IRF) signaling. After screening about 2% of the library, the study reported compounds suppressing NF-κB up to 15-fold or elevating NF-κB and IRF up to 5-fold and 6-fold, respectively. Follow-up cytokine assays found PME-4007 increased IFN-β secretion about threefold when co-delivered with the STING agonist cGAMP.

Technology: Machine-learning active-learning pipeline with variational-autoencoder molecular representations, Gaussian-process regression and Bayesian optimization

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: At the University of Chicago, an active-learning pipeline iteratively selected molecules from a 139,998-compound library for in-vitro assays of NF-κB and interferon regulatory factor (IRF) signaling.
  • Still unknown: The work reports in-vitro pathway modulation and primary-cell cytokine assays, not vaccination, immunotherapy efficacy, animal outcomes or clinical benefit. Fold changes are study-specific relative to agonist-only controls. A subset of candidates was further characterized; four tested compounds were flagged as non-viable by the cytostasis/cytotoxicity confluency mask despite strong pathway effects.
  • AI role: Models were iteratively trained on screening measurements and used Bayesian optimization to select subsequent compounds for in-vitro testing. This model-guided selection led to the reported NF-κB/IRF modulators; follow-up cytokine release assays tested a subset.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/38020385/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 86 of works of the same type, year and subfield (OpenAlex work metrics, 21 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.